Bernard J. Zovighian
At a glance: Bernard J. Zovighian is CEO at Edwards Lifesciences (EW). Their latest SEC Form 4, filed Nov 9, 2026, reported a sale of $949K. On file: 0 purchase lines ($0) and 10 sale lines ($9.4M).
Disclosed holdings: about $11.2M of EW stock: 107,761 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 9, 2026), valued at the Nov 19, 2026 close of $103.72. This counts only EW shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Bernard J. Zovighian's InsiderPrint
11 trades from SEC Form 4 filings, 2024 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 4 times a year, typically $322K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (1)
- Dent inward: a sale (10)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Lazarus KrikorianSvp & Chief Accounting Officer · COR · 100% match
- Sharon BrianskySvp, Gc And Secretary · ALGM · 99% match
- Heather L. HassonChair · FIGS · 99% match
- Ingrid A. EstradaSvp · KEYS · 99% match
- Alexandria ForbesCEO, President · MGTX · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 9,184112,761 held (−8%) | $103.39 | $949K | +0.3% |
| Nov 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 13,91698,845 held (−12%) | $102.78 | $1.4M | +0.9% |
| Jul 27SEC | EWEdwards Lifesciences Corp | Sell | 2,9218,916 held (−25%) | $83.93 | $245K | +23.6% |
| Jun 17SEC | EWEdwards Lifesciences Corp | Sell Plan | 52311,517 held (−4%) | $87.92 | $46K | +18.0% |
| May 12SEC | EWEdwards Lifesciences Corp | Sell Plan | 84547,546 held (−2%) | $78.40 | $66K | +32.3% |
| May 12SEC | EWEdwards Lifesciences Corp | Sell Plan | 35,50612,040 held (−75%) | $77.92 | $2.8M | +33.1% |
| Feb 13SEC | EWEdwards Lifesciences Corp | Sell | 2,532103,794 held (−2%) | $77.13 | $195K | +34.5% |
| Feb 13SEC | EWEdwards Lifesciences Corp | Sell | 19,89883,896 held (−19%) | $76.61 | $1.5M | +35.4% |
| Dec 10SEC | EWEdwards Lifesciences Corp | Sell Plan | 21,48784,839 held (−20%) | $85.21 | $1.8M | +21.7% |
| Dec 10SEC | EWEdwards Lifesciences Corp | Sell Plan | 3,8638,597 held (−31%) | $83.45 | $322K | +24.3% |
- Sell
CEO Bernard J Zovighian sold $949K of EW at $103.39 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Bernard J Zovighian sold $1.4M of EW at $102.78 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Bernard J Zovighian sold $46K of EW at $87.92 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Bernard J Zovighian sold $66K of EW at $78.40 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Bernard J Zovighian sold $2.8M of EW at $77.92 — cuts the stake by 75%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Bernard J Zovighian sold $1.8M of EW at $85.21 — pre-scheduled 10b5-1 plan sale.
Follow Bernard J. Zovighian
Get one email when Bernard J. Zovighian files a new purchase or sale. Free.
At most one email a day about Bernard J. Zovighian, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.